VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 4,191,854 Value ($000) $47,075 Avg Close — Range —
Q1 2025
Shares 3,955,099 Value ($000) $18,075 Avg Close — Range —
Q4 2024
Shares 4,006,634 Value ($000) $22,597 Avg Close — Range —
Q3 2024
Shares 4,005,161 Value ($000) $19,385 Avg Close — Range —
Q2 2024
Shares 5,263,509 Value ($000) $25,686 Avg Close — Range —
Q1 2024
Shares 6,331,312 Value ($000) $84,080 Avg Close — Range —
Q4 2023
Shares 5,471,930 Value ($000) $76,279 Avg Close — Range —
Q3 2023
Shares 4,832,968 Value ($000) $64,085 Avg Close — Range —
Q2 2023
Shares 4,091,215 Value ($000) $76,710 Avg Close — Range —
Q1 2023
Shares 3,878,850 Value ($000) $55,933 Avg Close — Range —
Q4 2022
Shares 3,812,024 Value ($000) $73,763 Avg Close — Range —
Q3 2022
Shares 3,658,812 Value ($000) $125,680 Avg Close — Range —
Q2 2022
Shares 2,342,193 Value ($000) $35,789 Avg Close — Range —
Q1 2022
Shares 2,318,775 Value ($000) $52,915 Avg Close — Range —
Q4 2021
Shares 1,364,221 Value ($000) $50,300 Avg Close — Range —
Q3 2021
Shares 1,282,542 Value ($000) $60,279 Avg Close — Range —
Q2 2021
Shares 65,000 Value ($000) $3,917 Avg Close — Range —